Formulation, Standardization, and Evaluation of A Polyherbal Churna for Antilipidemic Activity
International Journal of Drug Delivery Technology · 05.06.2026 · 16 (49s)
DOI: 10.25258/ijddt.16.49s.23 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 05.06.2026. Verfasst von Salunke P. R. und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Hyperlipidemia is one of the major metabolic disorders associated with elevated serum cholesterol, triglycerides, and low-density lipoproteins, leading to cardiovascular complications such as atherosclerosis, coronary artery disease, and stroke. Synthetic antihyperlipidemic drugs are effective but often produce adverse effects during long-term therapy.
Objective
The present investigation aimed to formulate and standardize a polyherbal churna containing medicinal plants possessing antihyperlipidemic, antioxidant, and cardioprotective properties. Materials and Methods The polyherbal formulation was prepared using authenticated herbal ingredients including Triphala, Guggul, Garlic, Fenugreek, and Turmeric. The prepared churna was evaluated for organoleptic characteristics, physicochemical parameters, phytochemical screening, flow properties, microbial load, and stability studies using standard pharmacognostic and pharmaceutical methods.
Results
The prepared formulation exhibited acceptable organoleptic properties with good flowability and stability. Physicochemical evaluation revealed pH 6.4, moisture content 4.25%, total ash value 6.80%, and satisfactory extractive values. Phytochemical analysis confirmed the presence of alkaloids, flavonoids, tannins, glycosides, phenolic compounds, and saponins. Microbial studies demonstrated that the formulation complied with pharmacopoeial limits. Stability studies indicated no significant changes in physicochemical and microbiological characteristics after storage.
Conclusion
The developed polyherbal churna demonstrated promising antihyperlipidemic potential due to the synergistic activity of multiple phytoconstituents. The formulation may serve as a safe, economical, and effective herbal alternative for the management of hyperlipidemia and associated cardiovascular disorders.
Zitieren
APA
R., S. P., S., K. O., R., S. G., & R., T. P. (2026). Formulation, Standardization, and Evaluation of A Polyherbal Churna for Antilipidemic Activity. International Journal of Drug Delivery Technology, 16(49s). https://doi.org/10.25258/ijddt.16.49s.23
Vancouver
R. SP, S. KO, R. SG, R. TP. Formulation, Standardization, and Evaluation of A Polyherbal Churna for Antilipidemic Activity. International Journal of Drug Delivery Technology. 2026;16(49s). doi:10.25258/ijddt.16.49s.23
BibTeX
@article{R2026,
author = {R., Salunke P. and S., Kharde O. and R., Sitaphale G. and R., Tathe P.},
title = {Formulation, Standardization, and Evaluation of A Polyherbal Churna for Antilipidemic Activity},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {49s},
doi = {10.25258/ijddt.16.49s.23}
}
EUVIMED